SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Interim Management Statement

1 Feb 2011 07:00

RNS Number : 4214A
Cranswick PLC
31 January 2011
 



1 February 2011

 

Cranswick plc ("Cranswick" or "the Company") - third quarter interim management statement

 

 

The three months to 31 December 2010 continued the positive trading performance seen in the first half of the year.

 

Underlying like-for-like sales increased by 5 per cent during the quarter, showing a slight increase on the rate of growth seen in the first half of the year. Volumes were ahead by 10 per cent on the same basis. Total sales for the third quarter were in line with those of the same period last year reflecting business transferred to the Farmers Boy (Deeside) Limited joint venture.

 

Overall operating margin was in line with management's expectations.

 

During the period, the new abattoir at the Company's primary pork processing site and the extension to the Lazenby's sausage facility, both in Hull, were completed and commissioning work continues at the Group's air-dried bacon facility at Sherburn-in-Elmet, near Leeds. These facilities provide the Company with substantial additional capacity and the potential to deliver on-going efficiency improvements.

 

Following the expected seasonal uplift in working capital and significant capital expenditure, net debt increased from £42 million to £54 million during the quarter, but was comfortably below the previous year's level of £67 million reflecting the strong cash generative nature of the business.

 

On 31 January the Company further strengthened its asset base by acquiring, for £7.3 million, the premises at Wombwell, near Barnsley, one of the Group's cooked meats facilities.

 

With experienced management throughout the Group and a well invested asset base, the Board, whilst mindful of the challenges facing the consumer this year, remains confident in the continued successful long term development of the business.

 

 

 

 

 

Enquiries:

 

Paul Quade 07947 186694

CityRoad Communications 020 7248 8010

 

 

 

 

Notes:

 

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2010 showed sales of £740m and profit before tax of £43.8m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement represents Cranswick's third quarter Interim Management Statement for the period from 1 October 2010 to 31 January 2011.

4. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAOKRAKAAOAR
Date   Source Headline
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.